IMMX vs AMGN: Which Stock is Better?

Side-by-side comparison of Immix Biopharma Inc and Amgen Inc in 2026

Comparison Updated:

IMMX

Immix Biopharma Inc

$9.85

AMGN

Amgen Inc

$350.95

Key Metrics Comparison

MetricIMMXAMGNWinner
Market Cap$513.69M$188.58BAMGN
P/E RatioN/A24.57AMGN
EPS (TTM)$N/A$14.24AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin0.0%70.8%AMGN

Analyze IMMX

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IMMX or AMGN a better investment?

Comparing IMMX and AMGN: Immix Biopharma Inc has a market cap of $513.69M while Amgen Inc has $188.58B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IMMX and AMGN?

IMMX (Immix Biopharma Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IMMX or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IMMX or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for IMMX.

Which company is more profitable: IMMX or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for IMMX.

Which is the larger company: IMMX or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $188.58B compared to $513.69M for IMMX.

Should I buy IMMX or AMGN in 2026?

Both IMMX and AMGN have investment merit. IMMX trades at $9.85 while AMGN trades at $350.95. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IMMX and AMGN stock?

Key differences: Market Cap ($513.69M vs $188.58B), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).

Popular Stock Comparisons